Search Results
Search for other papers by Christiaan F Mooij in
Google Scholar
PubMed
Department of Pediatric Endocrinology, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK
Search for other papers by Timothy D Cheetham in
Google Scholar
PubMed
Search for other papers by Frederik A Verburg in
Google Scholar
PubMed
Search for other papers by Anja Eckstein in
Google Scholar
PubMed
Endocrine Unit, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK
Search for other papers by Simon H Pearce in
Google Scholar
PubMed
Search for other papers by Juliane Léger in
Google Scholar
PubMed
Search for other papers by A S Paul van Trotsenburg in
Google Scholar
PubMed
Introduction Purpose and scope of guideline Hyperthyroidism caused by Graves’ disease (GD) is a relatively rare disease in children. Although treatment options are the same as in adults – antithyroid drugs (ATD), radioactive iodine (RAI
Department of Endocrinology, Universidade Federal do Rio de Janeiro – UFRJ, Faculdade de Medicina, Rio de Janeiro, RJ, Brazil
Search for other papers by Marise Codeco de Andrade Barreto in
Google Scholar
PubMed
Search for other papers by Natalia Treistman in
Google Scholar
PubMed
Search for other papers by Lara Bessa Campelo Pinheiro Cavalcante in
Google Scholar
PubMed
Search for other papers by Daniel Bulzico in
Google Scholar
PubMed
Search for other papers by Fernanda Accioly de Andrade in
Google Scholar
PubMed
Search for other papers by Rossana Corbo in
Google Scholar
PubMed
Department of Endocrinology, Universidade Federal do Rio de Janeiro – UFRJ, Faculdade de Medicina, Rio de Janeiro, RJ, Brazil
Search for other papers by Paulo Alonso Garcia Alves Junior in
Google Scholar
PubMed
Department of Endocrinology, Universidade Federal do Rio de Janeiro – UFRJ, Faculdade de Medicina, Rio de Janeiro, RJ, Brazil
Search for other papers by Fernanda Vaisman in
Google Scholar
PubMed
to treatment with iodine-131 (radioiodine (RAI)). However, controversy exists regarding the gonadotoxic effects of RAI in DTC survivors, which may include menstrual irregularity, miscarriage, premature ovarian failure, impaired fertility, and genetic
Search for other papers by Andrew J Bauer in
Google Scholar
PubMed
Search for other papers by Jonathan D Wasserman in
Google Scholar
PubMed
Search for other papers by Steven G Waguespack in
Google Scholar
PubMed
human thyroid-stimulating hormone for radioactive iodine (RAI) imaging and therapy, reducing the minimum time on a low-iodine diet to 4 days prior to 131 I, and modifying the recommendation for lifelong surveillance from the 2015 ATA Pediatric
Search for other papers by Chantal A Lebbink in
Google Scholar
PubMed
Search for other papers by Thera P Links in
Google Scholar
PubMed
Search for other papers by Agnieszka Czarniecka in
Google Scholar
PubMed
Search for other papers by Renuka P Dias in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Search for other papers by Louise Izatt in
Google Scholar
PubMed
Search for other papers by Heiko Krude in
Google Scholar
PubMed
Search for other papers by Kerstin Lorenz in
Google Scholar
PubMed
Search for other papers by Markus Luster in
Google Scholar
PubMed
Search for other papers by Kate Newbold in
Google Scholar
PubMed
Search for other papers by Arnoldo Piccardo in
Google Scholar
PubMed
Search for other papers by Manuel Sobrinho-Simões in
Google Scholar
PubMed
Search for other papers by Toru Takano in
Google Scholar
PubMed
Search for other papers by A S Paul van Trotsenburg in
Google Scholar
PubMed
Search for other papers by Frederik A Verburg in
Google Scholar
PubMed
Search for other papers by Hanneke M van Santen in
Google Scholar
PubMed
TSH levels after rhTSH stimulation of >50mIU. No significant side effects were reported. No studies reported on iodine uptake after rhTSH injection. ⊕⊕⊖⊖ 16. What is the difference in outcome in children with measurable but not rising Tg after
Search for other papers by Julia Ramalho Amalio da Silva Breder in
Google Scholar
PubMed
Search for other papers by Paulo Alonso Garcia Alves in
Google Scholar
PubMed
Search for other papers by Mario Lucio Araújo in
Google Scholar
PubMed
Search for other papers by Barbara Pires in
Google Scholar
PubMed
Search for other papers by Priscila Valverde in
Google Scholar
PubMed
Search for other papers by Daniel Alves Bulzico in
Google Scholar
PubMed
Search for other papers by Fernanda Andrade Accioly in
Google Scholar
PubMed
Search for other papers by Rossana Corbo in
Google Scholar
PubMed
Search for other papers by Mario Vaisman in
Google Scholar
PubMed
Endocrinology Department, Instituto Nacional do Cancer do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil
Search for other papers by Fernanda Vaisman in
Google Scholar
PubMed
dissection is not performed routinely and is only based on clinical or radiological suspicion of lymph node involvement. Most patients in our study received a therapeutic dose of radioactive iodine (RAI) after surgery, followed by suppressive therapy with
Search for other papers by Julia A Baran in
Google Scholar
PubMed
Search for other papers by Mya Bojarsky in
Google Scholar
PubMed
Search for other papers by Stephen Halada in
Google Scholar
PubMed
Search for other papers by Julio C Ricarte-Filho in
Google Scholar
PubMed
Search for other papers by Amber Isaza in
Google Scholar
PubMed
Search for other papers by Aime T Franco in
Google Scholar
PubMed
Search for other papers by Lea F Surrey in
Google Scholar
PubMed
Search for other papers by Tricia Bhatti in
Google Scholar
PubMed
Search for other papers by Zubair Baloch in
Google Scholar
PubMed
Search for other papers by N Scott Adzick in
Google Scholar
PubMed
Division of Oncology, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
Search for other papers by Sogol Mostoufi-Moab in
Google Scholar
PubMed
Department of Otorhinolaryngology: Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Search for other papers by Ken Kazahaya in
Google Scholar
PubMed
Search for other papers by Andrew J Bauer in
Google Scholar
PubMed
) staging, distant metastasis (M) staging, ATA risk status, radioactive iodine (RAI) therapy, lymphatic invasion, and response to therapy at 1 year post initial treatment. Genetic alterations were categorized by driver. ATA, American Thyroid Association